Analyze Diet
Journal of equine science2022; 33(3); 31-35; doi: 10.1294/jes.33.31

Serum proteins and electrophoretic profile in horses undergoing crotalid venom hyperimmunization.

Abstract: Indisputably, the use of antivenoms for the treatment of snakebite envenoming is beneficial for the victims. However, there are few studies addressing the effect of long-term hyperimmunization in inoculated horses. It is known that the injection of snake venoms and adjuvants leads to local and systemic reactions in horses, but little is known about the response of inflammatory proteins. The aim of this study was to evaluate serum proteins and the electrophoretic profile of horses undergoing crotalid venom hyperimmunization. Twenty horses were divided into two groups: an inoculated group, comprising ten horses that were already being used for production of a Crotalus sp. antivenom, and a control group, comprising ten animals that had never been used for hyperimmunization. All animals were clinically healthy and without laboratory abnormalities. Total protein and albumin concentrations were measured in serum. Serum globulins were obtained by calculation. Plasma fibrinogen estimates were determined by the heat precipitation method. Serum proteinograms were obtained using agarose gel electrophoresis. The results revealed a significant increase in the concentrations of total serum proteins, globulins, and β-globulins in the inoculated group, exceeding the reference values. There were slight increases in the α-1- and α-2-globulin subfractions in serum-producing horses, with no statistical significance. We also observed that horses used to produce hyperimmune plasma developed hypoalbuminemia, although the decrease in albumin production was not statistically significant. Our findings suggest that the continuous use of horses to produce crotalid antivenom may lead to a chronic inflammatory stimulus, with changes in plasma levels of inflammatory proteins.
Publication Date: 2022-09-21 PubMed ID: 36196141PubMed Central: PMC9522620DOI: 10.1294/jes.33.31Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the changes in serum proteins and electrophoretic profiles of horses undergoing extended periods of hyperimmunization with crotalid venom. The study establishes that persistently using horses for crotalid antivenom production might predispose them to chronic inflammation, altering their plasma levels of inflammation proteins.

Research Methodology

  • The study involved twenty horses divided into two groups – the inoculated group (10 horses) and the control group (10 horses).
  • The inoculated group horses were already being used for the production of Crotalus sp. antivenom while the control group horses had never been used for hyperimmunization.
  • All horses were clinically healthy and did not display any laboratory abnormalities.
  • Concentrations of total protein and albumin were measured in the horses’ serum. Serum globulins were obtained through calculation. Plasma fibrinogen estimates were determined via the heat precipitation method.
  • Serum proteinograms were obtained using agarose gel electrophoresis.

Findings

From the results gathered during the study, the researchers noticed several key points:

  • The concentrations of total serum proteins, globulins, and β-globulins were significantly higher in the inoculated group, exceeding the reference values.
  • There were slight increases in α-1- and α-2-globulin subfractions in serum-producing horses, although this increase was not statistically significant.
  • Horses used to produce hyperimmune plasma developed hypoalbuminemia, but the decrement in albumin production was not statistically significant.

Conclusion

The study suggests that continuous use of horses to produce crotalid antivenom results in a chronic inflammatory stimulus. This can cause changes in plasma levels of inflammatory proteins in those horses, which points to the potential physiological impact of recurring hyperimmunization. More research is needed to fully understand the long-term implications and potential harm to the horses.

Cite This Article

APA
Ramos MGDSN, Campos SDE, Strauch MA, Ott LC, Macieira DB, de Alencar NX, Lessa DAB. (2022). Serum proteins and electrophoretic profile in horses undergoing crotalid venom hyperimmunization. J Equine Sci, 33(3), 31-35. https://doi.org/10.1294/jes.33.31

Publication

ISSN: 1340-3516
NlmUniqueID: 9503751
Country: Japan
Language: English
Volume: 33
Issue: 3
Pages: 31-35

Researcher Affiliations

Ramos, Monique Gonçalves Dos Santos Novelino
  • Department of Pathology and Veterinary Clinics, Universidade Federal Fluminense, Niterói, 24.230-340, Rio de Janeiro, Brazil.
Campos, Sabrina Destri Emmerick
  • Department of Pathology and Veterinary Clinics, Universidade Federal Fluminense, Niterói, 24.230-340, Rio de Janeiro, Brazil.
Strauch, Marcelo Abrahão
  • Instituto Vital Brazil, Niterói, 24.430-210, Rio de Janeiro, Brazil.
Ott, Leila Cardozo
  • Universidade de Vassouras, Vassouras, 27.700-000, Rio de Janeiro, Brazil.
Macieira, Daniel de Barros
  • Department of Pathology and Veterinary Clinics, Universidade Federal Fluminense, Niterói, 24.230-340, Rio de Janeiro, Brazil.
de Alencar, Nayro Xavier
  • Department of Pathology and Veterinary Clinics, Universidade Federal Fluminense, Niterói, 24.230-340, Rio de Janeiro, Brazil.
Lessa, Daniel Augusto Barroso
  • Department of Pathology and Veterinary Clinics, Universidade Federal Fluminense, Niterói, 24.230-340, Rio de Janeiro, Brazil.

References

This article includes 23 references
  1. Angulo Y, Estrada R, Gutiérrez JM. Clinical and laboratory alterations in horses during immunization with snake venoms for the production of polyvalent (Crotalinae) antivenom.. Toxicon 1997 Jan;35(1):81-90.
    pubmed: 9028011doi: 10.1016/s0041-0101(96)00077-3google scholar: lookup
  2. Borges AS, Divers TJ, Stokol T, Mohammed OH. Serum iron and plasma fibrinogen concentrations as indicators of systemic inflammatory diseases in horses.. J Vet Intern Med 2007 May-Jun;21(3):489-94.
  3. Brasil. Manual de diagnóstico e tratamento dos acidentes por animais peçonhentos. p. 131.
  4. Ceron JJ, Eckersall PD, Martýnez-Subiela S. Acute phase proteins in dogs and cats: current knowledge and future perspectives.. Vet Clin Pathol 2005 Jun;34(2):85-99.
  5. Feitosa ES, Sampaio V, Sachett J, Castro DB, Noronha Md, Lozano JL, Muniz E, Ferreira LC, Lacerda MV, Monteiro WM. Snakebites as a largely neglected problem in the Brazilian Amazon: highlights of the epidemiological trends in the State of Amazonas.. Rev Soc Bras Med Trop 2015;48 Suppl 1:34-41.
    pubmed: 26061369doi: 10.1590/0037-8682-0105-2013google scholar: lookup
  6. Jacobsen S, Jensen JC, Frei S, Jensen AL, Thoefner MB. Use of serum amyloid A and other acute phase reactants to monitor the inflammatory response after castration in horses: a field study.. Equine Vet J 2005 Nov;37(6):552-6.
    pubmed: 16295934doi: 10.2746/042516405775314853google scholar: lookup
  7. Jain NC. Essentials of Veterinary Hematology. p. 417.
  8. Jain S, Gautam V, Naseem S. Acute-phase proteins: As diagnostic tool.. J Pharm Bioallied Sci 2011 Jan;3(1):118-27.
    pmc: PMC3053509pubmed: 21430962doi: 10.4103/0975-7406.76489google scholar: lookup
  9. Kaneko JJ, Harvey JW, Bruss ML. Clinical Biochemistry of Domestic Animals. p. 928.
  10. Machado C, Bochner RA. Informação dos acidentes crotálicos no Estado do Rio de Janeiro, 2001 a 2010. Gaz. méd. Bahia 82: 78–84.
  11. Martínez-Subiela S, Tecles F, Cerón JJ. Critical differences of acute phase proteins in canine serum samples.. Vet J 2003 Nov;166(3):233-7.
    pubmed: 14550733doi: 10.1016/s1090-0233(02)00315-5google scholar: lookup
  12. Meyer DJ, Harvey JW. Plasma proteins. pp. 156–168.
  13. Mills PC, Ng JC, Kramer H, Auer DE. Stress response to chronic inflammation in the horse.. Equine Vet J 1997 Nov;29(6):483-6.
  14. Murata H, Shimada N, Yoshioka M. Current research on acute phase proteins in veterinary diagnosis: an overview.. Vet J 2004 Jul;168(1):28-40.
    pubmed: 15158206doi: 10.1016/s1090-0233(03)00119-9google scholar: lookup
  15. Petersen HH, Nielsen JP, Heegaard PM. Application of acute phase protein measurements in veterinary clinical chemistry.. Vet Res 2004 Mar-Apr;35(2):163-87.
    pubmed: 15099494doi: 10.1051/vetres:2004002google scholar: lookup
  16. Puorto G. Divulgação científica sobre animais peçonhentos no Brasil. Gaz. méd. Bahia 82: 33–39.
  17. Sahal M, Altintas A, Arslan H, Ural K, Aksoy E. Serum hepatitis associated with administration of tetanus toxin in serum producing horses and therapy. Rev. Med. Vet. 155: 476–482.
  18. Silva RO, Lopes AF, Faria RMD. Eletroforese de proteínas séricas: interpretação e correlação clínica. Rev. Med. Minas 18: 116–122.
  19. Thomas JS. Overview of plasma proteins. pp. 891–898.
  20. Waghmare AB, Salvi NC, Deopurkar RL, Shenoy PA, Sonpetkar JM. Evaluation of health status of horses immunized with snake venom and montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) during polyvalent snake antivenom production: hematological and biochemical assessment.. Toxicon 2014 May;82:83-92.
    pubmed: 24582735doi: 10.1016/j.toxicon.2014.02.012google scholar: lookup
  21. World Health Organization. Rabies and envenomings: a neglected public health issue: report of a Consultative Meeting. 32p..
  22. Williams D, Gutiérrez JM, Harrison R, Warrell DA, White J, Winkel KD, Gopalakrishnakone P. The Global Snake Bite Initiative: an antidote for snake bite.. Lancet 2010 Jan 2;375(9708):89-91.
    pubmed: 20109867doi: 10.1016/s0140-6736(09)61159-4google scholar: lookup
  23. van Wuijckhuise-Sjouke LA. [Plasma fibrinogen as a parameter of the presence and severity of inflammation in horses and cattle].. Tijdschr Diergeneeskd 1984 Nov 1;109(21):869-72.
    pubmed: 6506055

Citations

This article has been cited 0 times.